Editas, after slow start, outlines plan to catch other CRISPR companies
“We’re in very different place,” the CEO of Editas says, citing the CRISPR pioneer’s plans to get its first treatments into trials.
“We’re in very different place,” the CEO of Editas says, citing the CRISPR pioneer’s plans to get its first treatments into trials.
Transgender and gender-diverse (TGD) individuals have a gender identity that does not align with the sex they were assigned at birth. In 2022, approximately 1.6%…
Discover the benefits of joining the National Medical Association, where healthcare professionals unite to drive change, advance their careers, and advocate for health equity. Membership…
Despite congressional failure to stop across-the-board cuts, CMS officials detailed efforts to boost prevention and primary care’s value.
Shadi Kourosh, MD, MPH, joins The Medical Sisterhood to discuss advocacy, mentorship, and the empowerment of women in medicine.
Teal Health raised $10 million in seed funding, taking its total funding to $23 million. The company has submitted an application to the FDA for…
Following the implementation of a new lung allocation system, Cleveland Clinic pulmonologists are working on further lowering waitlist times and patient mortality.
The CFPB’s rule was announced last November.
The CEOs of Eli Lilly and Pfizer weigh in on Trump, the FDA takes action on cigarettes and food dye, and more health care politics…
You’re even more likely to lose your job to a tech savvy worker: A staggering 70% of bosses surveyed plan to hire staff with AI…
Higher medical expenses combined with stricter government payment policies have pressured UnitedHealth’s earnings for more than a year.